Table 3.
Baseline characteristics of TTP patients in sensitivity analysis.
| Characteristic | Total cohort (N = 85) | Cohort with MACE (n = 30) | Cohort without MACE (n = 55) | P value |
|---|---|---|---|---|
| Age, y, median (IQR) | 54.0 (44.0,64.0) | 56.0 (45.0, 64.8) | 54.0 (44.0, 63.0) | .90 |
| Sex, % | .51 | |||
| Male | 30.6% | 36.7% | 27.3% | |
| Female | 69.4% | 63.3% | 72.7% | |
| Race, % | .44 | |||
| Black | 62.4% | 56.7% | 65.4% | |
| White | 34.1% | 36.7% | 32.8% | |
| Other | 3.5% | 6.6% | 1.8% | |
| Ethnicity, % | .29 | |||
| Not Hispanic or Latino | 76.5% | 70.0% | 80.% | |
| Hispanic or Latino | 1.2% | 3.3% | 0% | |
| Other/unknown | 22.3% | 26.7% | 20% | |
| Total cholesterol, mg/dL, median (IQR) | 173.0 (145.0, 210.8) | 169.0 (150.0, 205.0) | 177.0 (142.5, 211.5) | .71 |
| HDL cholesterol, mg/dL, median (IQR) | 46.0 (41.0, 62.0) | 46.0 (41.0, 59.8) | 47.0 (40.5,65.0) | .25 |
| LDL cholesterol, mg/dL, median (IQR) | 94.0 (79.8, 124.0) | 94.0 (81.0, 106.8) | 96.0 (76.5, 131.3) | .51 |
| Systolic blood pressure, median (IQR) | 131.0 (120.0, 146.8) | 144.0 (122.0, 162.0) | 128.0 (120.0, 140.0) | .05 |
| Diastolic blood pressure, median (IQR) | 73.5 (67.0, 82.0) | 71.0 (64.0, 85.0) | 74.0 (68.0, 81.0) | .62 |
| Antihypertensive medication, % | 67.1% | 70% | 65.5% | .85 |
| Smoker, % | 50.6% | 50.0% | 50.9% | .91 |
| Diabetes mellitus, % | 32.9% | 36.7% | 30.9% | .76 |
| Lupus or any autoimmune disease, % | 22.4% | 13.3% | 27.3% | .22 |
| History of DVT, % | 17.6% | 23.3% | 14.5% | .41 |
| History of CKD, % | 38.8% | 40.0% | 38.2% | .77 |
CKD, chronic kidney disease; DVT, deep vein thrombosis; HDL, high-density lipoprotein; IQR, interquartile range; LDL, low-density lipoprotein; MACE, major adverse cardiovascular event; TTP, thrombotic thrombocytopenic purpura.